Evaluating Emerging Clinical Strategies to Improve Trial Design & Patient Selection

2:30 pm - Tuesday 1st December 2026

  • Reviewing how quantitative imaging expertise, dosimetry capabilities and radiopharmacy infrastructure influence treatment consistency, patient management and overall clinical trial quality
  • Exploring which partners are best equipped to support multicentre TRP studies through reliable isotope handling, standardised imaging workflows and scalable radiopharmaceutical preparation
  • Exploring operational, technological and geographic considerations including software integration, site readiness, turnaround speed and regulatory compliance when selecting long-term dosimetry and radiopharmacy collaborators

Speakers:

President & Chief Executive Officer
Molecular Targeting Technologies